Minneapolis, MN (PRWEB) May 04, 2012
Advanced Circulatory Systems, Inc. announced today that it has received the Tibbetts Award from the U.S. Small Business Administration’s (SBA) Small Business Innovation Research (SBIR) program for the critical role they play in research and development and for their success in driving innovation. The company was recognized at a White House ceremony. Advanced Circulatory Systems also received the U.S. Army SBIR Achievement Award, for its ResQVENT™ transport ventilator.
Award criteria for the Tibbetts Award include research innovation and originality; relevance to the U.S. Army’s mission, immediate commercialization potential and overall quality performance of the project. Advanced Circulatory Systems was honored specifically for its work in developing and deploying an innovative therapy for the treatment of low blood pressure and elevated intracranial pressure.
The Tibbetts Awards is named after Roland Tibbetts, a leader in developing the SBIR program. The SBA said in its news announcement that the awards are presented to companies and individuals from across the United States who are “beacons of promise and models of excellence in high technology.” Advanced Circulatory Systems was one of 18 companies in the US recognized with this award and was one of two companies from Minnesota. Since its inception, Advanced Circulatory Systems has received over $17 million in funding from a combination of government grant sources including Department of Defense and National Institutes of Health.
The company’s first product, the ResQPOD® impedance threshold device, delivers its innovative pressure regulating therapy to cardiac arrest patients. This therapy creates a vacuum inside the chest cavity to enhance circulation and increase blood pressure. The product has been successfully deployed in military, emergency medical services (EMS) and hospital markets. The ResQGARD® impedance threshold device for breathing patients, was introduced to military and commercial emergency care markets in 2009.
The ResQVENT is an electronic, portable device that delivers novel Intrathoracic Pressure Regulation (IPR) therapy. It is designed for use on the battlefield and during transport of soldiers with traumatic brain injuries or hypotensive emergencies. Completion of the ResQVENT transport ventilator for IPR therapy is scheduled for 2012.
The Intrathoracic Pressure Regulation therapy and related products developed by Advanced Circulatory Systems have the support of more than 50 published clinical articles, demonstrating a 50 percent increase in blood flow and resuscitation outcomes. Since early in its development, Advanced Circulatory Systems has partnered with the Department of Defense and National Institutes of Health to support the research and development of products that treat the critical care needs of Army personnel as well as civilians.
About Advanced Circulatory Systems, Inc.
Advanced Circulatory Systems, Inc. is a privately held manufacturer of advanced circulatory technology based in Roseville, Minnesota (http://www.advancedcirculatory.com). Its mission is to restore life and improve the quality of life for patients experiencing cardiac arrest, low blood pressure and head injury by developing new technologies to non-invasively increase circulation throughout the body, improving opportunities for survival and quality of life. The company manufactures and markets the ResQPOD, a version of which is currently available for sale and in use at more than 1,200 hospitals and EMS systems throughout the US. More information on the company is available at http://www.advancedcirculatory.com. For company interviews or images, please contact jhenry(at)henryschafer(dot)com